谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

739 A Phase 1b/2, Open-Label, Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab for Participants with Immune Checkpoint Inhibitor (ICI) Refractory, or MSS/MSI-low ICI Naïve Advanced or Metastatic Solid Tumors

Han Myint,Eric Christenson,Siqing Fu,Martin Gutierrez, Ashley Martz,Stephanie Zeidan,Megan Nelson,Alina Barbu,Aaron Morawski,Chelsea Zhou,Zachary Cusumano, Rachel O'Neill,Ron Copeland,Dallas Flies,Solomon Langermann,Julia Cohen,Dung Le

Regular and Young Investigator Award Abstracts（2022）

引用 0|浏览16
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要